Literature DB >> 18716803

A foodborne outbreak of a group A streptococcal infection in a Japanese university hospital.

Y Takayama1, S Hikawa, J Okada, K Sunakawa, T Akahoshi.   

Abstract

We describe an outbreak of foodborne tonsillopharyngitis caused by group A streptococcus (GAS), a rarely reported event that occurred during a campus orientation meeting in Japan. Of 461 students and staff members who had eaten boxed lunches during a meeting at Kitasato University, 298 developed sore throat and/or fever, and 285 underwent medical examination. Amoxicillin was prescribed when throat culture specimens yielded GAS. The attack rate was 64.6%. T-25 GAS was isolated from 150 examined persons. Of 65 patients who received amoxicillin for 3 days, GAS was eradicated before the first follow-up throat culture in 46 (70.8%) cases. Susceptibility was demonstrated to penicillins, cephalosporins, and macrolides in 86 GAS isolates obtained more than once from a given patient. GAS strains isolated at various time points were indistinguishable by pulsed-field gel electrophoresis (PFGE), and prtF1 was present. GAS strains were often difficult to eradicate because of a short initial treatment period, patient compliance problems, and the presence of prtF1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716803     DOI: 10.1007/s10096-008-0614-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center.

Authors:  H Yano; M Suetake; A Kuga; K Irinoda; R Okamoto; T Kobayashi; M Inoue
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Failure of penicillin in Streptococcus pyogenes pharyngeal infection.

Authors:  S H Gillespie
Journal:  Lancet       Date:  1998 Dec 19-26       Impact factor: 79.321

Review 3.  Streptococcal pharyngitis: is penicillin still the right choice?

Authors:  M E Pichichero
Journal:  Compr Ther       Date:  1996-12

4.  Comparison between cefprozil and penicillin to eradicate pharyngeal colonization of group A beta-hemolytic streptococci.

Authors:  B B Standaert; K Finney; M T Taylor; R T Coleman; C L Horowitz; S M Walter; T F Murphy
Journal:  Pediatr Infect Dis J       Date:  1998-01       Impact factor: 2.129

5.  Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci.

Authors:  B Facinelli; C Spinaci; G Magi; E Giovanetti; P E Varaldo
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

Review 6.  Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies.

Authors:  M E Pichichero; J R Casey; T Mayes; A B Francis; S M Marsocci; A M Murphy; W Hoeger
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

7.  Group A streptococci efficiently invade human respiratory epithelial cells.

Authors:  D LaPenta; C Rubens; E Chi; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

8.  Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers.

Authors:  R Neeman; N Keller; A Barzilai; Z Korenman; S Sela
Journal:  Lancet       Date:  1998 Dec 19-26       Impact factor: 79.321

9.  Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.

Authors:  Prasit Mahakit; José Gil Vicente; D Iqbal Butt; German Angeli; Sanjay Bansal; David Zambrano
Journal:  Clin Ther       Date:  2006-01       Impact factor: 3.393

10.  Tonsillopharyngitis caused by foodborne group A streptococcus: a prison-based outbreak.

Authors:  Michael Levy; Christine G Johnson; Ed Kraa
Journal:  Clin Infect Dis       Date:  2003-01-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.